LAGUNA HILLS, Calif., March 12, 2019 — Sonendo, a market-leading dental technology company, and developer of the GentleWave® System, announced today that the company will be participating in the upcoming Oppenheimer’s 29th Annual Healthcare Conference on March 19-20th in New York City.
President and CEO, Bjarne Bergheim, is scheduled to present an update on the noteworthy U.S. market adoption of the GentleWave® Procedure and progress of Sonendo’s business growth strategy on Wednesday, March 20, 2019, at 1:00 pm EDT.
Sonendo, Inc. is a privately-held company developing innovative technology to transform dentistry by Saving Teeth Through Sound Science®. The first commercially available product from Sonendo, the GentleWave® System shows significant improvements in clinical efficacy and procedure efficiency when compared to standard root canal treatment.1,2,3
1Sigurdsson A et al. (2016) J Endod. 42:1040-48. 2Molina B et al. (2015) J Endod. 41:1701-05. 3Trope M et al. (1999) J Endod. 25:345–50.
This announcement contains forward-looking statements based on management’s beliefs, assumptions and expectations and information currently available to management. All statements that address events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations on the timing and progress of research and development activities. Management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made. Sonendo does not assume any obligation to update or revise any forward-looking statements publicly, whether as a result of new information, future events or otherwise. Actual results, developments or events could differ materially from those disclosed in the forward-looking statements.
Vice President of Marketing